Cosmos Health Inc. financial data

Symbol
COSM on Nasdaq
Location
5 Agiou Georgiou, Pilea, Thessaloniki, Greece
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % -30.2%
Quick Ratio 17.6 % -16.1%
Debt-to-equity 113 % +46.3%
Return On Equity -55.1 % +6.22%
Return On Assets -25.9 % +21.9%
Operating Margin -26.7 % +28.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.2M shares +71.6%
Common Stock, Shares, Outstanding 29.7M shares +67.4%
Entity Public Float 16.6M USD -42.5%
Common Stock, Value, Issued 29.8K USD +67.1%
Weighted Average Number of Shares Outstanding, Basic 28.8M shares +61.2%
Weighted Average Number of Shares Outstanding, Diluted 28.8M shares +61.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 55.1M USD -2.41%
Research and Development Expense 74.6K USD
Selling and Marketing Expense 120K USD -82.9%
General and Administrative Expense 11.9M USD -35.2%
Operating Income (Loss) -14.7M USD +29.9%
Nonoperating Income (Expense) -687K USD -0.56%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.4M USD +28.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -15.4M USD +28.7%
Earnings Per Share, Basic -1 USD/shares +54.4%
Earnings Per Share, Diluted -1 USD/shares +54.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.23M USD +297%
Marketable Securities, Current 30.3K USD +40.7%
Accounts Receivable, after Allowance for Credit Loss, Current 15.5M USD -15.9%
Inventory, Net 5.11M USD +18.2%
Assets, Current 30.6M USD -8.54%
Property, Plant and Equipment, Net 10.8M USD +7.62%
Operating Lease, Right-of-Use Asset 670K USD -7.8%
Intangible Assets, Net (Excluding Goodwill) 8.18M USD +6.64%
Goodwill 49.7K USD 0%
Other Assets, Noncurrent 1.23M USD
Assets 61.8M USD +1.66%
Accrued Liabilities, Current 222K USD +33.3%
Liabilities, Current 31.2M USD +25.6%
Operating Lease, Liability, Noncurrent 453K USD -3.87%
Other Liabilities, Noncurrent 1.93M USD +90.1%
Liabilities 35.6M USD +24%
Accumulated Other Comprehensive Income (Loss), Net of Tax 459K USD
Retained Earnings (Accumulated Deficit) -118M USD -22.4%
Stockholders' Equity Attributable to Parent 26.2M USD -18.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 26M USD -35.9%
Liabilities and Equity 61.8M USD +1.66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -186K USD +94.5%
Net Cash Provided by (Used in) Financing Activities 561K USD +171%
Net Cash Provided by (Used in) Investing Activities -7.07K USD -106%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 29.8M shares +67.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 428K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 656K USD +90.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 105K USD -55.4%
Depreciation 387K USD +9.63%
Payments to Acquire Property, Plant, and Equipment 12.5K USD -84.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.9M USD +32%
Property, Plant and Equipment, Gross 12.5M USD +10.6%
Operating Lease, Liability, Current 216K USD -15.2%
Deferred Tax Assets, Operating Loss Carryforwards 38.5M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Operating Lease, Payments 41.1K USD +67.8%
Additional Paid in Capital 144M USD +10.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 869K USD +69.1%
Depreciation, Depletion and Amortization 312K USD +335%
Share-based Payment Arrangement, Expense -214K USD -100%
Interest Expense 1.08M USD +7.81%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%